Cargando…

Adherence to European Association of Urology Guidelines and State of the Art of Glycosaminoglycan Therapy for the Management of Urinary Tract Infections: A Narrative Review and Expert Meeting Report

CONTEXT: Urinary tract infections (UTIs) have a significant impact on patient’s quality of life and society. Antibiotic therapy is the primary approach for the management of UTIs; however, it has major limits in the prevention of recurrent UTIs (rUTIs), also increasing the risk of development of mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonkat, Gernot, Cai, Tommaso, Galeone, Carlotta, Koves, Bela, Bruyere, Franck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424561/
https://www.ncbi.nlm.nih.gov/pubmed/36051173
http://dx.doi.org/10.1016/j.euros.2022.07.009
_version_ 1784778249900916736
author Bonkat, Gernot
Cai, Tommaso
Galeone, Carlotta
Koves, Bela
Bruyere, Franck
author_facet Bonkat, Gernot
Cai, Tommaso
Galeone, Carlotta
Koves, Bela
Bruyere, Franck
author_sort Bonkat, Gernot
collection PubMed
description CONTEXT: Urinary tract infections (UTIs) have a significant impact on patient’s quality of life and society. Antibiotic therapy is the primary approach for the management of UTIs; however, it has major limits in the prevention of recurrent UTIs (rUTIs), also increasing the risk of development of multidrug-resistant micro-organisms. OBJECTIVE: The aim of this paper is to discuss the European Association of Urology guidelines for the management of UTIs/rUTIs, the level of adherence to these recommendations, and the available evidence on the use of glycosaminoglycans (GAGs) as a possible alternative treatment to prevent rUTIs. EVIDENCE ACQUISITION: This narrative review and expert meeting report is based on a literature search concerning the currently available UTI guidelines, the results of a survey administered to 227 urologists, and the opinion of an expert panel in the field of UTIs. EVIDENCE SYNTHESIS: Results obtained from the literature search showed that adherence to guidelines is not optimal. The survey demonstrated that antibiotics remain one of the treatments of UTIs. However, most of the urologists are aware of the problem caused by the resistance to antibiotics and prefer alternative methods for the prophylaxis of UTIs. Considering the alternative methods, the authors concluded that GAG therapy is highly effective in preventing rUTIs. CONCLUSIONS: Adherence to the international guidelines is important to align the clinical practice and avoid the spreading of antibiotic resistance. The survey outlines that the misuse and overuse of antibiotics are major problems; an analysis of clinical evidence confirms that GAG therapy is a valuable therapeutic approach to prevent the recurrence of episodes of UTIs and to limit the onset of antibiotic resistance. PATIENT SUMMARY: Although antibiotic therapy is primarily used for the management of urinary tract infections (UTIs), misuse and overuse of antibiotics are of concern. Adherence to the international guidelines is important to prevent the spreading of antibiotic resistance. Clinical evidence confirms that the use of glycosaminoglycans is a valuable therapeutic approach to prevent UTI recurrence and limit the onset of antibiotic resistance.
format Online
Article
Text
id pubmed-9424561
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94245612022-08-31 Adherence to European Association of Urology Guidelines and State of the Art of Glycosaminoglycan Therapy for the Management of Urinary Tract Infections: A Narrative Review and Expert Meeting Report Bonkat, Gernot Cai, Tommaso Galeone, Carlotta Koves, Bela Bruyere, Franck Eur Urol Open Sci Review – Infections CONTEXT: Urinary tract infections (UTIs) have a significant impact on patient’s quality of life and society. Antibiotic therapy is the primary approach for the management of UTIs; however, it has major limits in the prevention of recurrent UTIs (rUTIs), also increasing the risk of development of multidrug-resistant micro-organisms. OBJECTIVE: The aim of this paper is to discuss the European Association of Urology guidelines for the management of UTIs/rUTIs, the level of adherence to these recommendations, and the available evidence on the use of glycosaminoglycans (GAGs) as a possible alternative treatment to prevent rUTIs. EVIDENCE ACQUISITION: This narrative review and expert meeting report is based on a literature search concerning the currently available UTI guidelines, the results of a survey administered to 227 urologists, and the opinion of an expert panel in the field of UTIs. EVIDENCE SYNTHESIS: Results obtained from the literature search showed that adherence to guidelines is not optimal. The survey demonstrated that antibiotics remain one of the treatments of UTIs. However, most of the urologists are aware of the problem caused by the resistance to antibiotics and prefer alternative methods for the prophylaxis of UTIs. Considering the alternative methods, the authors concluded that GAG therapy is highly effective in preventing rUTIs. CONCLUSIONS: Adherence to the international guidelines is important to align the clinical practice and avoid the spreading of antibiotic resistance. The survey outlines that the misuse and overuse of antibiotics are major problems; an analysis of clinical evidence confirms that GAG therapy is a valuable therapeutic approach to prevent the recurrence of episodes of UTIs and to limit the onset of antibiotic resistance. PATIENT SUMMARY: Although antibiotic therapy is primarily used for the management of urinary tract infections (UTIs), misuse and overuse of antibiotics are of concern. Adherence to the international guidelines is important to prevent the spreading of antibiotic resistance. Clinical evidence confirms that the use of glycosaminoglycans is a valuable therapeutic approach to prevent UTI recurrence and limit the onset of antibiotic resistance. Elsevier 2022-08-23 /pmc/articles/PMC9424561/ /pubmed/36051173 http://dx.doi.org/10.1016/j.euros.2022.07.009 Text en © 2022 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review – Infections
Bonkat, Gernot
Cai, Tommaso
Galeone, Carlotta
Koves, Bela
Bruyere, Franck
Adherence to European Association of Urology Guidelines and State of the Art of Glycosaminoglycan Therapy for the Management of Urinary Tract Infections: A Narrative Review and Expert Meeting Report
title Adherence to European Association of Urology Guidelines and State of the Art of Glycosaminoglycan Therapy for the Management of Urinary Tract Infections: A Narrative Review and Expert Meeting Report
title_full Adherence to European Association of Urology Guidelines and State of the Art of Glycosaminoglycan Therapy for the Management of Urinary Tract Infections: A Narrative Review and Expert Meeting Report
title_fullStr Adherence to European Association of Urology Guidelines and State of the Art of Glycosaminoglycan Therapy for the Management of Urinary Tract Infections: A Narrative Review and Expert Meeting Report
title_full_unstemmed Adherence to European Association of Urology Guidelines and State of the Art of Glycosaminoglycan Therapy for the Management of Urinary Tract Infections: A Narrative Review and Expert Meeting Report
title_short Adherence to European Association of Urology Guidelines and State of the Art of Glycosaminoglycan Therapy for the Management of Urinary Tract Infections: A Narrative Review and Expert Meeting Report
title_sort adherence to european association of urology guidelines and state of the art of glycosaminoglycan therapy for the management of urinary tract infections: a narrative review and expert meeting report
topic Review – Infections
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424561/
https://www.ncbi.nlm.nih.gov/pubmed/36051173
http://dx.doi.org/10.1016/j.euros.2022.07.009
work_keys_str_mv AT bonkatgernot adherencetoeuropeanassociationofurologyguidelinesandstateoftheartofglycosaminoglycantherapyforthemanagementofurinarytractinfectionsanarrativereviewandexpertmeetingreport
AT caitommaso adherencetoeuropeanassociationofurologyguidelinesandstateoftheartofglycosaminoglycantherapyforthemanagementofurinarytractinfectionsanarrativereviewandexpertmeetingreport
AT galeonecarlotta adherencetoeuropeanassociationofurologyguidelinesandstateoftheartofglycosaminoglycantherapyforthemanagementofurinarytractinfectionsanarrativereviewandexpertmeetingreport
AT kovesbela adherencetoeuropeanassociationofurologyguidelinesandstateoftheartofglycosaminoglycantherapyforthemanagementofurinarytractinfectionsanarrativereviewandexpertmeetingreport
AT bruyerefranck adherencetoeuropeanassociationofurologyguidelinesandstateoftheartofglycosaminoglycantherapyforthemanagementofurinarytractinfectionsanarrativereviewandexpertmeetingreport